Status:
RECRUITING
InsightRP2 Registry
Lead Sponsor:
University of Göttingen
Conditions:
RP2-associated Retinitis Pigmentosa
X-Linked Retinitis Pigmentosa (XLRP)
Eligibility:
All Genders
Brief Summary
InsightRP2 is a secure online patient registry specific to RP2-associated retinitis pigmentosa (RP). It is our goal to further the scientific understanding of this rare disease and to support research...
Detailed Description
There is currently no specific patient registry for RP2-associated retinitis pigmentosa. Due to the rarity of the disease, only a few patients with this disease are seen at various care sites, making ...
Eligibility Criteria
Inclusion
- A molecular genetic diagnosis involving a heterozygous or hemizygous variant in RP2 and a written informed consent to participate are required for access to the registry questionnaire. Patients of all ages meeting the above criteria will be allowed to participate. As documentation will be in English and German, those who can navigate these pages will be included.
Exclusion
- Patients with evidence of non-RP2 molecular genetic diagnoses will be excluded. Collection of data and further analysis will not be possible without the consent of the patient or legal guardian. Patients who cannot navigate registry documentation in English or German will be excluded.
Key Trial Info
Start Date :
May 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2045
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06982417
Start Date
May 1 2025
End Date
May 1 2045
Last Update
May 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medicine Göttingen
Göttingen, Lower Saxony, Germany, 37073